LEP and metabolic dysfunction-associated steatotic liver disease: Moreover, the procarcinogenic roles of leptin and associated liver diseases (i.e., NAFLD) have been linked to the promotion of CRC cell invasiveness via the activation of the MAPK signaling pathway [44].